CRVO (CervoMed) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CRVO CervoMed Inc CRVO
35 GF Score
Price $2.63
! 2 Warning Signs
View Full Analysis

What is CervoMed FFO per Share?

FFO per Share only applies to REITs.

CRVO
35GF Score
CervoMed Inc CRVO
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CervoMed Business Description

Other Exchanges DP8:Germany
Address 20 Park Plaza, Suite 424, Boston, MA, USA, 02116
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
35GF Score

Get the complete analysis for CRVO

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.63
Price